Advances in antithrombotic therapy as adjunct to reperfusion therapies for ST-segment elevation myocardial infarction

Keyphrases

• ST-elevation Myocardial Infarction (STEMI) 100%
• Reperfusion Therapy 100%
• Antithrombotic Therapy 100%
• Abciximab 60%
• Primary Angioplasty 40%
• Reinfarction 40%
• Unfractionated Heparin 40%
• Bivalirudin 40%
• Peri-procedural 20%
• Randomized Trial 20%
• High Risk 20%
• Recanalization 20%
• Myocardial Infarction Patients 20%
• Bleeding Complications 20%
• Myocardial Perfusion 20%
• Mechanical Revascularization 20%
• Clopidogrel 20%
• Low Mortality 20%
• Improved Outcomes 20%
• Infarct Size 20%
• Review Update 20%
• Thrombolysis 20%
• Anticoagulant Therapy 20%
• Low Molecular Weight Heparin 20%
• Enoxaparin 20%
• Direct Thrombin Inhibitors 20%
• Reperfusion Strategy 20%

Pharmacology, Toxicology and Pharmaceutical Science

• ST Segment Elevation Myocardial Infarction 100%
• Antithrombotic Therapy 100%
• Abciximab 60%
• Heparin 40%
• Bivalirudin 40%
• Infarction 20%
• Bleeding 20%
• Clopidogrel 20%
• Acetylsalicylic Acid 20%
• Enoxaparin 20%
• Low Molecular Weight Heparin 20%
• Thrombin Inhibitor 20%
• Anticoagulation Therapy 20%